SCID Mouse Models of Human Stem Cell Engraftment
暂无分享,去创建一个
[1] J. D. Funkhouser,et al. Cancer susceptibility in ataxia-telangiectasia. , 1992, Leukemia.
[2] D. Greiner,et al. High levels of human peripheral blood mononuclear cell engraftment and enhanced susceptibility to human immunodeficiency virus type 1 infection in NOD/LtSz-scid/scid mice. , 1995, The Journal of infectious diseases.
[3] L. Shultz,et al. Defective repair of radiation-induced chromosomal damage in scid/scid mice. , 1992, Cytogenetics and cell genetics.
[4] P. Lansdorp,et al. Characterization and partial purification of human marrow cells capable of initiating long-term hematopoiesis in vitro. , 1989, Blood.
[5] J. Gaedeke,et al. Hematopoietic stem-cell defects underlying abnormal macrophage development and maturation in NOD/Lt mice: defective regulation of cytokine receptors and protein kinase C. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[6] V. Stewart,et al. RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement , 1992, Cell.
[7] E. Leiter,et al. Defective activation of T suppressor cell function in nonobese diabetic mice. Potential relation to cytokine deficiencies. , 1988, Journal of immunology.
[8] J. Dick,et al. Immature human cord blood progenitors engraft and proliferate to high levels in severe combined immunodeficient mice. , 1994, Blood.
[9] Der,et al. An in vitro limiting-dilution assay of long-term repopulating hematopoietic stem cells in the mouse. , 1989, Blood.
[10] J. Roder,et al. High level functional engraftment of severe combined immunodeficient mice with human peripheral blood lymphocytes following pretreatment with radiation and anti-asialo GM1. , 1994, Journal of immunological methods.
[11] G. Shearer,et al. Evidence for a similar or common mechanism for natural killer cell activity and resistance to hemopoietic grafts , 1977, European journal of immunology.
[12] C. Eaves,et al. Expansion in vitro of transplantable human cord blood stem cells demonstrated using a quantitative assay of their lympho-myeloid repopulating activity in nonobese diabetic-scid/scid mice. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[13] D. Harrison. Competitive repopulation: a new assay for long-term stem cell functional capacity. , 1980, Blood.
[14] C. Raker,et al. Severe combined immunodeficiency mice engrafted with human T cells, B cells, and myeloid cells after transplantation with human fetal bone marrow or liver cells and implanted with human fetal thymus: a model for studying human gene therapy. , 1997, Blood.
[15] W. Vainchenker,et al. Phenotype and function of human hematopoietic cells engrafting immune-deficient CB17-severe combined immunodeficiency mice and nonobese diabetic-severe combined immunodeficiency mice after transplantation of human cord blood mononuclear cells. , 1996, Blood.
[16] M. Bennett,et al. Murine natural killer cells and marrow graft rejection. , 1992, Annual review of immunology.
[17] P. Quesenberry,et al. Improved engraftment of human cord blood stem cells in NOD/LtSz-scid/scid mice after irradiation or multiple-day injections into unirradiated recipients. , 1996, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[18] H. Mcdevitt,et al. Prevention of diabetes in nonobese diabetic mice by tumor necrosis factor (TNF): similarities between TNF-alpha and interleukin 1. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[19] H. Sugiyama,et al. The scid mutation in mice causes defects in the repair system for both double-strand DNA breaks and DNA cross-links. , 1993, Mutation research.
[20] M. Roncarolo,et al. Phenotypic and Functional Evidence for the Expression of CD 4 by Hematopoietic Stem Cells Isolated From Human Fetal Liver , 1997 .
[21] G. Aldrovandi,et al. The SCID-hu mouse: an in-vivo model for HIV-1 pathogenesis and stem cell gene therapy for AIDS. , 1996, Seminars in immunology.
[22] R. Giavazzi,et al. Transfer of the ADA gene into human ADA-deficient T lymphocytes reconstitutes specific immune functions. , 1992, Blood.
[23] S. Jackson,et al. DNA double-strand break repair , 1999, Current Biology.
[24] T. Kollmann,et al. Reconstitution of SCID mice with human lymphoid and myeloid cells after transplantation with human fetal bone marrow without the requirement for exogenous human cytokines. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[25] Naomi Rosenberg,et al. The defect in murine severe combined immune deficiency: Joining of signal sequences but not coding segments in V(D)J recombination , 1988, Cell.
[26] J. Dick,et al. Normal and leukemic SCID-repopulating cells (SRC) coexist in the bone marrow and peripheral blood from CML patients in chronic phase, whereas leukemic SRC are detected in blast crisis. , 1996, Blood.
[27] David A. Williams,et al. Identification of primitive human hematopoietic cells capable of repopulating NOD/SCID mouse bone marrow: Implications for gene therapy , 1996, Nature Medicine.
[28] J. Zack,et al. Modeling human lymphoid precursor cell gene therapy in the SCID-hu mouse. , 1994, Blood.
[29] Y. Shimosato,et al. Leukemic distribution of a human acute lymphocytic leukemia cell line (Ichikawa strain) in nude mice conditioned with whole-body irradiation. , 1978, Cancer research.
[30] G. Almeida-Porada,et al. Retention and multilineage expression of human hematopoietic stem cells in human‐sheep chimeras , 1995, Stem cells.
[31] J. Dick,et al. Differential maintenance of primitive human SCID-repopulating cells, clonogenic progenitors, and long-term culture-initiating cells after incubation on human bone marrow stromal cells. , 1997, Blood.
[32] I. Weissman,et al. The SCID-hu mouse: murine model for the analysis of human hematolymphoid differentiation and function. , 1988, Science.
[33] J. Dick,et al. A model of human acute lymphoblastic leukemia in immune-deficient SCID mice. , 1989, Science.
[34] H. Kaneshima,et al. The SCID-hu mouse: an in vivo model for HIV-1 infection in humans. , 1997, Molecular medicine today.
[35] J. Dick,et al. Gene transfer into normal human hematopoietic cells using in vitro and in vivo assays. , 1991, Blood.
[36] G. Almeida-Porada,et al. The human/sheep xenograft model: a large animal model of human hematopoiesis. , 1996, International journal of hematology.
[37] P. Quesenberry,et al. Detection of a human CFC with a high proliferative potential. , 1989, Blood.
[38] J. Dick,et al. Engraftment of immune-deficient mice with human hematopoietic stem cells. , 1988, Science.
[39] M. Ladanyi,et al. Administration of rabbit anti-asialo GM1 antiserum facilitates the development of human Epstein-Barr virus-induced lymphoproliferations in xenografted C.B-17 scid/scid mice. , 1996, Transplantation.
[40] N. Saijo,et al. Long-term human hematopoiesis in SCID-hu mice bearing transplanted fragments of adult bone and bone marrow cells. , 1995, Blood.
[41] H. Colten,et al. Complement deficiencies. , 1992, Annual review of immunology.
[42] A. Carroll,et al. The SCID mouse mutant: definition, characterization, and potential uses. , 1991, Annual review of immunology.
[43] R. Hoffman,et al. Primitive human hematopoietic cells displaying differential efflux of the rhodamine 123 dye have distinct biological activities. , 1996, Blood.
[44] Susumu Tonegawa,et al. RAG-1-deficient mice have no mature B and T lymphocytes , 1992, Cell.
[45] T. Nakahata,et al. Hemopoietic colony-forming cells in umbilical cord blood with extensive capability to generate mono- and multipotential hemopoietic progenitors. , 1982, The Journal of clinical investigation.
[46] J. Dick,et al. SCID mice as an in vivo model of human cord blood hematopoiesis. , 1994, Blood cells.
[47] Z. Eshhar,et al. Engraftment and development of human T and B cells in mice after bone marrow transplantation. , 1991, Science.
[48] J. Roder,et al. Improved engraftment of human tumours in SCID mice pretreated with radiation and anti-asialo GM1. , 1994, Anticancer research.
[49] P. Jeggo,et al. Identification of a nonsense mutation in the carboxyl-terminal region of DNA-dependent protein kinase catalytic subunit in the scid mouse. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[50] G. Pinkus,et al. The development of a model for the homing of multiple myeloma cells to human bone marrow. , 1997, Blood.
[51] M. Fried,et al. Evidence of functional lymphocytes in some (leaky) scid mice , 1988, The Journal of experimental medicine.
[52] Thomas O. Toole,et al. Hematopoietic potential of cryopreserved and ex vivo manipulated umbilical cord blood progenitor cells evaluated in vitro and in vivo. , 1996, Blood.
[53] J. D. de Vries,et al. Human T-and B-cell functions in SCID-hu mice. , 1996, Seminars in immunology.
[54] J. McCune,et al. Development and applications of the SCID-hu mouse model. , 1996, Seminars in immunology.
[55] J. Dick,et al. Purification of primitive human hematopoietic cells capable of repopulating immune-deficient mice. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[56] P. Quesenberry. The blueness of stem cells. , 1991, Experimental hematology.
[57] P. Quesenberry,et al. Ex vivo expansion of murine marrow cells with interleukin-3 (IL-3), IL-6, IL-11, and stem cell factor leads to impaired engraftment in irradiated hosts. , 1996, Blood.
[58] J. Dick,et al. Engraftment of immune-deficient mice with primitive hematopoietic cells from beta-thalassemia and sickle cell anemia patients: implications for evaluating human gene therapy protocols. , 1995, Human molecular genetics.
[59] J. Dick,et al. Kinetic evidence of the regeneration of multilineage hematopoiesis from primitive cells in normal human bone marrow transplanted into immunodeficient mice. , 1997, Blood.
[60] E. Leiter,et al. Emv30null NOD-scid Mice: An Improved Host for Adoptive Transfer of Autoimmune Diabetes and Growth of Human Lymphohematopoietic Cells , 1995, Diabetes.
[61] G. Beamer,et al. Role of natural killer cells on engraftment of human lymphoid cells and on metastasis of human T-lymphoblastoid leukemia cells in C57BL/6J-scid mice and in C57BL/6J-scid bg mice. , 1996, Cellular immunology.
[62] D. Schatz,et al. A link between double-strand break-related repair and V(D)J recombination: the scid mutation. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[63] S. Jagannath,et al. Enrichment of human hematopoietic stem cell activity in the CD34+Thy-1+Lin- subpopulation from mobilized peripheral blood. , 1995, Blood.
[64] G. Crooks,et al. Extended long-term culture reveals a highly quiescent and primitive human hematopoietic progenitor population. , 1996, Blood.
[65] H. Gaskins,et al. Defects in the differentiation and function of antigen presenting cells in NOD/Lt mice. , 1993, Journal of immunology.
[66] N. Van Rooijen,et al. The role of natural antibodies and ABO (H) blood groups in transplantation of human lymphoid cells into mice , 1993, European journal of immunology.
[67] R. Hoffman,et al. Human allogeneic stem cell maintenance and differentiation in a long-term multilineage SCID-hu graft. , 1995, Blood.
[68] D. Rosenstreich,et al. Inherent Macrophage Defects in Mice , 1981 .
[69] H. Kikutani,et al. The murine autoimmune diabetes model: NOD and related strains. , 1992, Advances in immunology.
[70] S. Gallinger,et al. Human primary immune response in SCID mice engrafted with human peripheral blood lymphocytes. , 1994, Journal of immunology.
[71] D. Catovsky,et al. Growth of human T-cell lineage acute leukemia in severe combined immunodeficiency (SCID) mice and non-obese diabetic SCID mice. , 1997, Blood.
[72] D. Vestweber,et al. L-Selectin from Human, but Not from Mouse Neutrophils Binds Directly to E-Selectin , 1997, The Journal of cell biology.
[73] J. McCune,et al. Use of standardized SCID-hu Thy/Liv mouse model for preclinical efficacy testing of anti-human immunodeficiency virus type 1 compounds , 1996, Antimicrobial agents and chemotherapy.
[74] I. Kimber. Immunologic Defects in Laboratory Animals , 1982, British Journal of Cancer.
[75] B. Haynes,et al. Successful engraftment of human postnatal thymus in severe combined immune deficient (SCID) mice: differential engraftment of thymic components with irradiation versus anti-asialo GM-1 immunosuppressive regimens , 1991, The Journal of experimental medicine.
[76] D. Haviland,et al. Deficiency of the murine fifth complement component (C5). A 2-base pair gene deletion in a 5'-exon. , 1990, The Journal of biological chemistry.
[77] G. Wagemaker,et al. Long-term leukemia-initiating capacity of a CD34-subpopulation of acute myeloid leukemia. , 1996, Blood.
[78] J. Dick,et al. Cytokine stimulation of multilineage hematopoiesis from immature human cells engrafted in SCID mice. , 1992, Science.
[79] F. Alt,et al. The scid defect affects the final step of the immunoglobulin VDJ recombinase mechanism , 1988, Cell.
[80] A. Giaccia,et al. scid mutation in mice confers hypersensitivity to ionizing radiation and a deficiency in DNA double-strand break repair. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[81] D. Bodine,et al. Improved engraftment of human hematopoietic cells in severe combined immunodeficient (SCID) mice carrying human cytokine transgenes , 1995, The Journal of experimental medicine.
[82] M. Caligiuri,et al. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice , 1994, Nature.
[83] K. Azueimita,et al. Nonsense mutation at Tyr-4046 in the DNA-dependent protein kinase catalytic subunit of severe combined immune deficiency mice , 1997 .
[84] S. Jackson,et al. Gene for the catalytic subunit of mouse DNA-dependent protein kinase maps to the scid locus. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[85] R. A. Phillips,et al. The scid mutation in mice causes a general defect in DNA repair , 1990, Nature.
[86] P. Jeggo,et al. Identification of the catalytic subunit of DNA dependent protein kinase as the product of the mouse scid gene. , 1996, Current topics in microbiology and immunology.
[87] D. Greiner,et al. Improved engraftment of human spleen cells in NOD/LtSz-scid/scid mice as compared with C.B-17-scid/scid mice. , 1995, The American journal of pathology.
[88] N. Carballido‐Perrig,et al. Antigen-specific cytotoxic T cells mediate human fetal pancreas allograft rejection in SCID-hu mice. , 1996, Journal of immunology.
[89] M. Bergman,et al. Establishment and Characterization of RAG‐2 Deficient Non‐Obese Diabetic Mice , 1996, Scandinavian journal of immunology.
[90] B. Chen,et al. Delineation of T-progenitor cell activity within the CD34+ compartment of adult bone marrow. , 1995, Blood.
[91] M. Oettinger,et al. DNA-dependent kinase (p350) as a candidate gene for the murine SCID defect , 1995, Science.
[92] J. Dick,et al. Differential kinetics of engraftment and induction of CD10 on human pre-B leukemia cell lines in immune deficient scid mice. , 1992, Leukemia.
[93] M. Roncarolo,et al. Phenotypic and functional evidence for the expression of CD4 by hematopoietic stem cells isolated from human fetal liver. , 1997, Blood.
[94] A. Galy,et al. Engraftment of human hematopoietic precursor cells with secondary transfer potential in SCID-hu mice. , 1994, Blood.
[95] A. Giaccia,et al. The DNA damage response in DNA-dependent protein kinase-deficient SCID mouse cells: replication protein A hyperphosphorylation and p53 induction. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[96] Competitive repopulation: a new assay for long-term stem cell functional capacity. , 1980 .
[97] D. Ganick,et al. Inability of intravenously injected monocellular suspensions of human bone marrow to establish in the nude mouse. , 1980, International archives of allergy and applied immunology.
[98] R. Hoffman,et al. High-level expression of a novel epitope of CD59 identifies a subset of CD34+ bone marrow cells highly enriched for pluripotent stem cells. , 1996, Experimental hematology.
[99] J. Dick,et al. Differential Maintenance of Primitive Human SCID-Repopulating Cells, Clonogenic Progenitors, and Long-Term Culture-Initiating Cells After Incubation on Human Bone Marrow Stromal Cells , 1997 .
[100] J. Dick,et al. Engraftment and development of human CD34(+)-enriched cells from umbilical cord blood in NOD/LtSz-scid/scid mice. , 1997, Blood.
[101] I. Bernstein,et al. Strain-dependent leakiness of mice with severe combined immune deficiency. , 1993, Journal of immunology.
[102] Quesenberry Pj. The blueness of stem cells. , 1991 .
[103] J. Mirra,et al. Induction of new-bone formation in the host bed by human bone-tumor transplants in athymic nude mice. , 1979, The Journal of bone and joint surgery. American volume.
[104] P. Hochman,et al. Do Natural Killer Cells Engage in Regulated Reactions Against Self to Ensure Homeostasis? , 1979, Immunological reviews.
[105] D. Greiner,et al. Multiple defects in innate and adaptive immunologic function in NOD/LtSz-scid mice. , 1995, Journal of immunology.
[106] T. Saito,et al. Nonsense mutation at Tyr-4046 in the DNA-dependent protein kinase catalytic subunit of severe combined immune deficiency mice. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[107] J. Dick,et al. Primitive human hematopoietic cells are enriched in cord blood compared with adult bone marrow or mobilized peripheral blood as measured by the quantitative in vivo SCID-repopulating cell assay. , 1997, Blood.
[108] R. Custer,et al. A severe combined immunodeficiency mutation in the mouse , 1983, Nature.
[109] A. Cooke,et al. Complement lytic activity has no role in the pathogenesis of autoimmune diabetes in NOD mice. , 1993, Diabetes.
[110] J. Dick,et al. Quantitative Analysis Reveals Expansion of Human Hematopoietic Repopulating Cells After Short-term Ex Vivo Culture , 1997, The Journal of experimental medicine.
[111] Donald E. Mosier,et al. Transfer of a functional human immune system to mice with severe combined immunodeficiency , 1988, Nature.
[112] A. Berrebi,et al. A model for human B-chronic lymphocytic leukemia in human/mouse radiation chimera: evidence for tumor-mediated suppression of antibody production in low-stage disease. , 1997, Blood.
[113] D. Roopenian,et al. Enhanced human CD4+ T cell engraftment in beta2-microglobulin-deficient NOD-scid mice. , 1997, Journal of immunology.
[114] J. McCune,et al. Human hematolymphoid cells in SCID mice. , 1994, Current opinion in immunology.
[115] P. Quesenberry,et al. Murine marrow cells expanded in culture with IL-3, IL-6, IL-11, and SCF acquire an engraftment defect in normal hosts. , 1995, Experimental hematology.
[116] P. Alexander,et al. Studies on the development of human acute myeloid leukaemia xenografts in immune-deprived mice: comparison with cells in short-term culture. , 1985, Leukemia research.
[117] J. Wagner,et al. Isolation of small, primitive human hematopoietic stem cells: distribution of cell surface cytokine receptors and growth in SCID-Hu mice. , 1995, Blood.
[118] P. Unger,et al. Engraftment of human lymphocytes and thyroid tissue into scid and rag2-deficient mice: absent progression of lymphocytic infiltration. , 1994, The Journal of clinical endocrinology and metabolism.
[119] G. Tricot,et al. Analysis of human hematopoietic stem cell populations. , 1994, Blood cells.
[120] J. Satoh,et al. Immunologic Aspects of the Nonobese Diabetic (NOD) Mouse: Abnormalities of Cellular Immunity , 1983, Diabetes.
[121] W. Fleming,et al. Sustained multilineage engraftment of allogeneic hematopoietic stem cells in NOD/SCID mice after in utero transplantation. , 1997, Blood.
[122] H. Gaskins,et al. The nonobese diabetic scid mouse: model for spontaneous thymomagenesis associated with immunodeficiency. , 1992, Proceedings of the National Academy of Sciences of the United States of America.